The Europe Motion Sickness Treatment Market would witness market growth of 3.0% CAGR during the forecast period (2023-2029).
The motion sickness treatment market is experiencing growth due to various factors, including a rise in the occurrence of motion sickness, an increase in demand for efficient treatments, and an upsurge in research and development efforts in the pharmaceutical industry. The pharmaceutical industry is experiencing growth and innovation in manufacturing motion sickness medications. This is due to the large population that experiences motion sickness, which presents a significant opportunity for market growth.
In recent years, there has been an increase in the number of approved products for motion sickness medication. The rise in the adoption of medications, including transdermal patches and other drugs, can be attributed to the approvals granted for both generic and branded versions. This drives the expansion of the market. Moreover, the increase in consumer knowledge regarding preventative healthcare and the convenience of accessing medications drives the uptake of motion sickness medications. Furthermore, the manufacturers' boost in promotional activities for new products is anticipated to drive their adoption throughout the projected period.
The United Kingdom's over-the-counter (OTC) drugs sector is expected to experience growth in the next few years due to increasing investments and expenses in pharmaceutical products and therapeutics. The UK's OTC drugs industry is expected to experience growth in the coming years due to increased government investment in the pharmaceutical industry and rising consumer demand for advanced and affordable pharmaceutical products. This investment is aimed at promoting local manufacturers and boosting the overall economy. Hence, with the growing adoption of OTC drugs to counter minor health issues to save cost and time for the user, the utilization of OTC-based drugs like antihistamines and anticholinergics will also increase to treat motion sickness and therefore drive the market expansion in Europe.
The Germany market dominated the Europe Motion Sickness Treatment Market by Country in 2022; thereby, achieving a market value of $33.1 Million by 2029. The UK market is estimated to grow at a CAGR of 2.2% during (2023 - 2029). Additionally, The France market would register a CAGR of 3.8% during (2023 - 2029).
Based on Drug Class, the market is segmented into Antihistamines, Anticholinergics and Others. Based on Route of Administration, the market is segmented into Oral and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Motion Sickness Treatment Market is Projected to reach USD 481 Million by 2029, at a CAGR of 3.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG, Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Prestige Consumer Healthcare, Inc., WellSpring Pharmaceutical Corporation (Avista Capital Partners).
Scope of the Study
Market Segments Covered in the Report:
By Drug Class
- Antihistamines
- Anticholinergics
- Others
By Route of Administration
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Viatris, Inc.
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Baxter International, Inc.
- Novartis AG
- Abbott Laboratories
- Sun Pharmaceutical Industries Ltd.
- Zydus Lifesciences Ltd.
- Prestige Consumer Healthcare, Inc.
- WellSpring Pharmaceutical Corporation (Avista Capital Partners)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Motion Sickness Treatment Market, by Drug Class
1.4.2 Europe Motion Sickness Treatment Market, by Route of Administration
1.4.3 Europe Motion Sickness Treatment Market, by Distribution Channel
1.4.4 Europe Motion Sickness Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Motion Sickness Treatment Market by Drug Class
3.1 Europe Antihistamines Market by Country
3.2 Europe Anticholinergics Market by Country
3.3 Europe Others Market by Country
Chapter 4. Europe Motion Sickness Treatment Market by Route of Administration
4.1 Europe Oral Market by Country
4.2 Europe Others Market by Country
Chapter 5. Europe Motion Sickness Treatment Market by Distribution Channel
5.1 Europe Drug Store & Retail Pharmacies Market by Country
5.2 Europe Hospital Pharmacies Market by Country
5.3 Europe Online Pharmacies Market by Country
Chapter 6. Europe Motion Sickness Treatment Market by Country
6.1 Germany Motion Sickness Treatment Market
6.1.1 Germany Motion Sickness Treatment Market by Drug Class
6.1.2 Germany Motion Sickness Treatment Market by Route of Administration
6.1.3 Germany Motion Sickness Treatment Market by Distribution Channel
6.2 UK Motion Sickness Treatment Market
6.2.1 UK Motion Sickness Treatment Market by Drug Class
6.2.2 UK Motion Sickness Treatment Market by Route of Administration
6.2.3 UK Motion Sickness Treatment Market by Distribution Channel
6.3 France Motion Sickness Treatment Market
6.3.1 France Motion Sickness Treatment Market by Drug Class
6.3.2 France Motion Sickness Treatment Market by Route of Administration
6.3.3 France Motion Sickness Treatment Market by Distribution Channel
6.4 Russia Motion Sickness Treatment Market
6.4.1 Russia Motion Sickness Treatment Market by Drug Class
6.4.2 Russia Motion Sickness Treatment Market by Route of Administration
6.4.3 Russia Motion Sickness Treatment Market by Distribution Channel
6.5 Spain Motion Sickness Treatment Market
6.5.1 Spain Motion Sickness Treatment Market by Drug Class
6.5.2 Spain Motion Sickness Treatment Market by Route of Administration
6.5.3 Spain Motion Sickness Treatment Market by Distribution Channel
6.6 Italy Motion Sickness Treatment Market
6.6.1 Italy Motion Sickness Treatment Market by Drug Class
6.6.2 Italy Motion Sickness Treatment Market by Route of Administration
6.6.3 Italy Motion Sickness Treatment Market by Distribution Channel
6.7 Rest of Europe Motion Sickness Treatment Market
6.7.1 Rest of Europe Motion Sickness Treatment Market by Drug Class
6.7.2 Rest of Europe Motion Sickness Treatment Market by Route of Administration
6.7.3 Rest of Europe Motion Sickness Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Viatris, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expense
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Amneal Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.4 Baxter International, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.4.4 Research & Development Expense
7.5 Novartis AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Abbott Laboratories
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Zydus Lifesciences Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Trials and Approvals:
7.9 Prestige Consumer Healthcare, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.10. WellSpring Pharmaceutical Corporation (Avista Capital Partners)
7.10.1 Company Overview
TABLE 1 Europe Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 2 Europe Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 3 Europe Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 Europe Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 5 Europe Antihistamines Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Antihistamines Market by Country, 2023 - 2029, USD Million
TABLE 7 Europe Anticholinergics Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Anticholinergics Market by Country, 2023 - 2029, USD Million
TABLE 9 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 11 Europe Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 12 Europe Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 13 Europe Oral Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Oral Market by Country, 2023 - 2029, USD Million
TABLE 15 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 17 Europe Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 Europe Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 Europe Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 21 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 23 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 Europe Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
TABLE 27 Germany Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 28 Germany Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 29 Germany Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 30 Germany Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 31 Germany Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 32 Germany Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 33 Germany Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 Germany Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 UK Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 36 UK Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 37 UK Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 UK Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 39 UK Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 40 UK Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 41 UK Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 UK Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 France Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 44 France Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 45 France Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 46 France Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 47 France Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 48 France Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 49 France Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 France Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 Russia Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 52 Russia Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 53 Russia Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 54 Russia Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 55 Russia Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Russia Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 57 Russia Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Russia Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 Spain Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 60 Spain Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 61 Spain Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 62 Spain Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 63 Spain Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 64 Spain Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 65 Spain Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 Spain Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 67 Italy Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 68 Italy Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 69 Italy Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 70 Italy Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 71 Italy Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 72 Italy Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 73 Italy Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Italy Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 75 Rest of Europe Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 76 Rest of Europe Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 77 Rest of Europe Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 78 Rest of Europe Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 79 Rest of Europe Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 80 Rest of Europe Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 81 Rest of Europe Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of Europe Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 83 key information – Viatris, Inc.
TABLE 84 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 85 Key Information – Amneal Pharmaceuticals, INc.
TABLE 86 Key Information – Baxter International, Inc.
TABLE 87 Key Information – Novartis AG
TABLE 88 Key Information – Abbott Laboratories
TABLE 89 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 90 Key Information – Zydus Lifesciences Ltd.
TABLE 91 Key Information – Prestige consumer healthcare inc.
TABLE 92 Key Information – WellSpring Pharmaceutical Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories